| COVID 19 hospitalized | |
| COVID-19 severe or critically | |
| hydroxychloroquine | REMAP-CAP-HCQ HYDRA ... Sarhan Sarhan Mahevas Yu |
| 5560 | BCN PEP-CoV-2-Study 2 (Mitja Lancet-preprint), 2020 | 2 | 1 | 2 | excluded | ||
| 5564 | Kanran M, 2020 | 2 | 1 | 0 | excluded | risk of bias not avaialble | |
| 5776 | Alberici, 2020 | 2 | 13 | 4 | excluded | not a RCT | high risk of bias |
| 5864 | HYDRA, 2020 | 2 | 1 | 0 | excluded | risk of bias not avaialble | |
| 6032 | Mohana, 2020 | 2 | 12 | 0 | excluded | not a RCT | risk of bias not avaialble |
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
